Classification of High Intensity Zones of the Lumbar Spine and Their Association with Other Spinal MRI Phenotypes: The Wakayama Spine Study

published_or_final_versio

UniCarbKB: building a knowledge platform for glycoproteomics

The UniCarb KnowledgeBase (UniCarbKB; http://unicarbkb.org) offers public access to a growing, curated database of information on the glycan structures of glycoproteins. UniCarbKB is an international effort that aims to further our understanding of structures, pathways and networks involved in glycosylation and glyco-mediated processes by integrating structural, experimental and functional glycoscience information. This initiative builds upon the success of the glycan structure database GlycoSuiteDB, together with the informatic standards introduced by EUROCarbDB, to provide a high-quality and updated resource to support glycomics and glycoproteomics research. UniCarbKB provides comprehensive information concerning glycan structures, and published glycoprotein information including global and site-specific attachment information. For the first release over 890 references, 3740 glycan structure entries and 400 glycoproteins have been curated. Further, 598 protein glycosylation sites have been annotated with experimentally confirmed glycan structures from the literature. Among these are 35 glycoproteins, 502 structures and 60 publications previously not included in GlycoSuiteDB. This article provides an update on the transformation of GlycoSuiteDB (featured in previous NAR Database issues and hosted by ExPASy since 2009) to UniCarbKB and its integration with UniProtKB and GlycoMod. Here, we introduce a refactored database, supported by substantial new curated data collections and intuitive user-interfaces that improve database searchin

Experimental study of the decay KL0→π0ννˉK_L^0\to\pi^0\nu\bar{\nu}

The first dedicated search for the rare neutral-kaon decay $K_L^0\to\pi^0\nu\bar{\nu}$ has been carried out in the E391a experiment at the KEK 12-GeV proton synchrotron. The final upper limit of 2.6 $\times 10^{-8}$ at the 90% confidence level was set on the branching ratio for the decay.Comment: 23 pages, 27 figures, accepted for publication as a regular article in Physical Review

Study of the K0(L) --> pi0 pi0 nu nu-bar decay

The rare decay K0(L) --> pi0 pi0 nu nu-bar was studied with the E391a detector at the KEK 12-GeV proton synchrotron. Based on 9.4 x 10^9 K0L decays, an upper limit of 8.1 x 10^{-7} was obtained for the branching fraction at 90% confidence level. We also set a limit on the K0(L) --> pi0 pi0 X (X --> invisible particles) process; the limit on the branching fraction varied from 7.0 x 10^{-7} to 4.0 x 10^{-5} for the mass of X ranging from 50 MeV/c^2 to 200 MeV/c^2.Comment: 5 pages, 5 figure

Search for the decay KL0→3γK_L^0 \rightarrow 3\gamma

We performed a search for the decay $K_L^0 \rightarrow 3\gamma$ with the E391a detector at KEK. In the data accumulated in 2005, no event was observed in the signal region. Based on the assumption of $K_L^0 \rightarrow 3\gamma$ proceeding via parity-violation, we obtained the single event sensitivity to be $(3.23\pm0.14)\times10^{-8}$, and set an upper limit on the branching ratio to be $7.4\times10^{-8}$ at the 90% confidence level. This is a factor of 3.2 improvement compared to the previous results. The results of $K_L^0 \rightarrow 3\gamma$ proceeding via parity-conservation were also presented in this paper

Some remarks on the dynamical systems approach to fourth order gravity

Building on earlier work, we discuss a general framework for exploring the cosmological dynamics of Higher Order Theories of Gravity. We show that once the theory of gravity has been specified, the cosmological equations can be written as a first-order autonomous system and we give several examples which illustrate the utility of our method. We also discuss a number of results which have appeared recently in the literature.Comment: 19 pages, LaTe

Accelerating Universes in String Theory via Field Redefinition

We study cosmological solutions in the effective heterotic string theory with $\alpha'$-correction terms in string frame. It is pointed out that the effective theory has an ambiguity via field redefinition and we analyze generalized effective theories due to this ambiguity. We restrict our analysis to the effective theories which give equations of motion of second order in the derivatives, just as "Galileon" field theory. This class of effective actions contains two free coupling constants. We find de Sitter solutions as well as the power-law expanding universes in our four-dimensional Einstein frame. The accelerated expanding universes are always the attractors in the present dynamical system.Comment: 22 pages, 3 figures, some additional formulae adde

Human Umbilical Cord Blood-Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities

Osteoporosis is a bone disorder associated with loss of bone mineral density and micro architecture. A balance of osteoblasts and osteoclasts activities maintains bone homeostasis. Increased bone loss due to increased osteoclast and decreased osteoblast activities is considered as an underlying cause of osteoporosis.The cures for osteoporosis are limited, consequently the potential of CD34+ cell therapies is currently being considered. We developed a nanofiber-based expansion technology to obtain adequate numbers of CD34(+) cells isolated from human umbilical cord blood, for therapeutic applications. Herein, we show that CD34(+) cells could be differentiated into osteoblastic lineage, in vitro. Systemically delivered CD34(+) cells home to the bone marrow and significantly improve bone deposition, bone mineral density and bone micro-architecture in osteoporotic mice. The elevated levels of osteocalcin, IL-10, GM-CSF, and decreased levels of MCP-1 in serum parallel the improvements in bone micro-architecture. Furthermore, CD34(+) cells improved osteoblast activity and concurrently impaired osteoclast differentiation, maturation and functionality.These findings demonstrate a novel approach utilizing nanofiber-expanded CD34(+) cells as a therapeutic application for the treatment of osteoporosis